The report provides comprehensive information on the therapeutics under development for Asthma, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Asthma and features dormant and discontinued projects.
Browse the Full Report @ http://www.orbisresearch.com/reports/index/asthma-pipeline-review-h1-2016 .
Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.
The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.
Check the Discount for this Report @ http://www.orbisresearch.com/contacts/discount/144099 .
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data.
– The report provides a snapshot of the global therapeutic landscape of Asthma
– The report reviews pipeline therapeutics for Asthma by companies and universities/research institutes based on information derived from company and industry-specific sources
– The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
– The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
– The report reviews key players involved Asthma therapeutics and enlists all their major and minor projects
– The report assesses Asthma therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
– The report summarizes all the dormant and discontinued pipeline projects
– The report reviews latest news related to pipeline therapeutics for Asthma
Reasons to buy
– Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
– Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
– Identify and understand important and diverse types of therapeutics under development for Asthma
– Identify potential new clients or partners in the target demographic
– Develop strategic initiatives by understanding the focus areas of leading companies
– Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics
– Devise corrective measures for pipeline projects by understanding Asthma pipeline depth and focus of Indication therapeutics
– Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
– Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline
Request a Sample of this Report @ http://www.orbisresearch.com/contacts/request-sample/144099 .
Companies Mentioned in this Research Report:
4D Pharma Plc
AB Science SA
Accolade Pharmaceuticals, LLC
Acorda Therapeutics, Inc.
Adamis Pharmaceuticals Corporation
Advinus Therapeutics Ltd.
Afferent Pharmaceuticals, Inc.
Allergopharma GmbH & Co. KG
Antisense Therapeutics Limited
Aquinox Pharmaceuticals Inc.
ARA Healthcare Pvt. Ltd.
Ario Pharma Ltd
ASIT biotech s.a.
Aslan Pharmaceuticals Pte. Ltd.
Astellas Pharma Inc.
Asubio Pharma Co., Ltd.
Aurigene Discovery Technologies Limited
Axikin Pharmaceuticals, Inc.
Bioncotech Therapeutics S.L.
Biotec Pharmacon ASA
Boehringer Ingelheim GmbH
Caladrius Biosciences, Inc.
Carolus Therapeutics, Inc.
Cellular Biomedicine Group, Inc.
Celon Pharma Sp. z o.o.
Chiesi Farmaceutici SpA
Chong Kun Dang Pharmaceutical Corp.
Circassia Pharmaceuticals Plc
Cumberland Pharmaceuticals, Inc.
Daiichi Sankyo Company, Limited
Dynavax Technologies Corporation
F. Hoffmann-La Roche Ltd.
Five Prime Therapeutics, Inc.
Foresee Pharmaceuticals, LLC
Fountain Biopharma Inc.
Glenmark Pharmaceuticals Ltd.
Griffin Discoveries BV
Hanmi Pharmaceuticals, Co. Ltd.
Hydra Biosciences, Inc.
iCo Therapeutics Inc.
Infinity Pharmaceuticals, Inc.
INOXIA Lifesciences GmbH
Jiangsu Hansoh Pharmaceutical Co., Ltd.
Johnson & Johnson
Kissei Pharmaceutical Co., Ltd.
Kolltan Pharmaceuticals, Inc.
Kyowa Hakko Kirin Co., Ltd.
Laboratoires Pierre Fabre SA
Lead Discovery Center GmbH
LegoChem Biosciences, Inc
Ligand Pharmaceuticals, Inc.
Marinomed Biotechnologie GmbH
Merck & Co., Inc.
Mitsubishi Tanabe Pharma Corporation
Mycenax Biotech Inc.
NAL Pharmaceuticals Ltd.
NeoPharm Co., Ltd.
Nostrum Pharmaceuticals, LLC
Ono Pharmaceutical Co., Ltd.
OPKO Health, Inc.
Orbis Biosciences, Inc.
Palatin Technologies, Inc.
Panacea Biotec Limited
Panmira Pharmaceuticals, LLC.
Pulmagen Therapeutics LLP
Regeneron Pharmaceuticals, Inc.
ReveraGen BioPharma, Inc.
Rhizen Pharmaceuticals S.A.
Saje Pharma, LLC
Spring Bank Pharmaceuticals, Inc.
sterna biologicals Gmbh & Co KG
Sumitomo Dainippon Pharma Co., Ltd.
Sun Pharma Advanced Research Company Ltd.
Sunovion Pharmaceuticals Inc.
Syntrix Biosystems, Inc.
Takeda Pharmaceutical Company Limited
Teva Pharmaceutical Industries Ltd.
The International Biotechnology Center (IBC) Generium
Therabron Therapeutics, Inc.
Theraclone Sciences, Inc.
Theravance Biopharma, Inc.
United BioPharma, Inc.
Vectura Group Plc
Verona Pharma Plc
WhanIn Pharmaceutical Co., Ltd.
Yungjin Pharm. Co., Ltd.
Zambon Company S.p.A.
Ziarco Pharma Ltd
Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customised reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialisation. This helps our clients to map their needs and we produce the perfect required market research study for our clients.
Senior Manager – Client Engagements
4144N Central Expressway,
Suite 600, Dallas,
Texas – 75204, U.S.A.
Phone No.: +1 (214) 884-6817; +912064101019